Simon Senanu: Key Laboratory Markers of Hemolytic Anemia
Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:
“Hemolytic Anemia – Key Laboratory Markers
Hemolytic anemia is not just about low hemoglobin – it’s about increased red cell destruction.
And in the lab, the evidence is often unmistakable.
What Is Hemolytic Anemia?
Hemolytic anemia occurs when:
- Red blood cell destruction exceeds bone marrow production
It can be broadly classified as:
- Intravascular hemolysis – destruction within the circulation
- Extravascular hemolysis – destruction by macrophages in the spleen and liver
- The distinction is critical, as it directly influences both laboratory findings and clinical presentation.
Core Laboratory Markers
The diagnosis relies on a combination of findings:
- Elevated Lactate Dehydrogenase (LDH) – Reflects cellular breakdown; often markedly increased in intravascular hemolysis
- Increased Unconjugated Bilirubin – Result of heme catabolism; may lead to clinical jaundice
- Reduced Haptoglobin – Binds free hemoglobin; levels drop as it is consumed – Often undetectable in intravascular hemolysis
- Reticulocytosis -Indicates marrow compensation, Reticulocyte count may rise within 3 – 5 days of hemolysis
A high reticulocyte count with anemia strongly suggests a hemolytic process.
Peripheral Blood Smear Findings
The blood film is indispensable in narrowing the cause:
- Schistocytes – Microangiopathic hemolytic anemia (e.g., TTP, DIC)
- Spherocytes – Autoimmune hemolytic anemia or hereditary spherocytosis
- Bite cells / Heinz body remnants – Oxidative damage (e.g., G6PD deficiency)
- Polychromasia – Reflects increased circulating reticulocytes
In many cases, the smear provides the first clue to etiology before confirmatory testing.
Intravascular vs Extravascular Clues
- Intravascular hemolysis
- Hemoglobinemia
- Hemoglobinuria
- Markedly low haptoglobin
Extravascular hemolysis
- Splenomegaly
- Spherocytes on smear
- Mildly reduced haptoglobin
- These patterns help localize where destruction is occurring.
Additional Diagnostic Tests
To further define etiology:
- Direct Antiglobulin Test (DAT / Coombs test) – Autoimmune hemolysis
- G6PD assay – Enzyme deficiency (note: may be falsely normal during acute episodes)
- Hemoglobin electrophoresis – Hemoglobinopathies
- Osmotic fragility test – Hereditary spherocytosis
Laboratory Pitfalls
- Recent transfusion may mask hemolysis markers
- Liver disease can alter bilirubin interpretation
- Inflammation may falsely elevate haptoglobin
Always interpret results in clinical context.
Clinical Significance
Early recognition of hemolysis is critical for:
- Diagnosing autoimmune hemolytic anemia
- Detecting transfusion reactions
- Identifying inherited RBC disorders
Laboratory Takeaway
Hemolytic anemia is a pattern-based diagnosis.
No single test is sufficient – interpretation requires integrating:
- Biochemistry plus Hematology plus Morphology
Which marker do you find most reliable in early hemolysis – LDH, haptoglobin, or the peripheral smear?”
Stay updated with Hemostasis Today.
-
Mar 28, 2026, 19:04Roberta Gualtierotti: High Engagement for Research on Non-Replacement Therapies in Hemophilia
-
Mar 28, 2026, 19:02Marking a Century of Progress in von Willebrand Disease – HFA
-
Mar 28, 2026, 18:57Jim Hoffman: NETosis Dysregulation Links Cancer Progression and Autoimmunity
-
Mar 28, 2026, 18:55Ifeanyichukwu Ifechidere: Which Coagulation Factors Are Not Involved in Bleeding?
-
Mar 28, 2026, 18:54Examining Critical Gaps in AF Stroke Prevention – JTH
-
Mar 28, 2026, 18:51Asad Ikram: Headache and Visual Impairment in Idiopathic Intracranial Hypertension
-
Mar 28, 2026, 18:48Abdul Mannan: How SSRIs Might Affect Platelet Function
-
Mar 28, 2026, 18:47Cedric Hermans: A Useful Platform for Daily Practice in Hemostasis
-
Mar 28, 2026, 18:41Amy Delderfield: One Trial, Big Implications for Anticoagulant Choice